Fusion Pharmaceuticals Inc. Total Long-Term Debt
Fusion Pharmaceuticals Inc. had Total Long-Term Debt of $35.00 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2024-05-07
- 2023-12-31: Long-term Debt $35.00M.
- 2023-09-30: Long-term Debt $50.00M; Long-term Debt as first filed $35.00M.
- 2023-06-30: Long-term Debt $35.00M.
- 2023-03-31: Long-term Debt $35.00M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2023-12-31 | $35.00M 10-K · filed 2024-03-20 | |
| 2023-09-30 | $50.00M 10-Q · filed 2024-05-07 | $35.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $35.00M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $35.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $35.00M 10-K · filed 2023-03-16 | |
| 2022-09-30 | $35.00M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-09 |